CS logo
small CS logo
SMBD Jewish Gen Hosp

Montreal, Quebec, Canada
Hospital in Montreal, Quebec
3755 Chem. de la Côte-Sainte-Catherine, Montréal, QC H3T 1E2
637 Beds

About SMBD Jewish Gen Hosp


The Jewish General Hospital, known officially as the Sir Mortimer B. Davis Jewish General Hospital since 1978, is an acute-care teaching hospital in Montreal, Quebec, Canada. The hospital is affiliated with McGill University and has 637 beds, one of the most of a hospital site in Canada.
There are 637 beds in SMBD Jewish Gen Hosp.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at SMBD Jewish Gen Hosp


During the past decade, SMBD Jewish Gen Hosp conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "SMBD Jewish Gen Hosp" #1 collaborator was "Schering-Plough" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at SMBD Jewish Gen Hosp


According to Clinical.Site data, the most researched conditions in "SMBD Jewish Gen Hosp" are "Chronic Hepatitis C" (1 trials) and "HIV Infections" (1 trials). Many other conditions were trialed in "SMBD Jewish Gen Hosp" in a lesser frequency.

Clinical Trials Intervention Types at SMBD Jewish Gen Hosp


Most popular intervention types in "SMBD Jewish Gen Hosp" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Indinavir sulfate" (1 trials), "Nelfinavir mesylate" (1 trials), "Peginterferon alfa-2b (Pegetron) plus ribavirin (Rebetol)" (1 trials) and "Ritonavir" (1 trials). Other intervention names were less common.

Clinical Trials Genders at SMBD Jewish Gen Hosp


The vast majority of trials in "SMBD Jewish Gen Hosp" are 2 trials for "All" genders.

Clinical Trials Status at SMBD Jewish Gen Hosp


Currently, there are NaN active trials in "SMBD Jewish Gen Hosp". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in SMBD Jewish Gen Hosp, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in SMBD Jewish Gen Hosp, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".